REMERON

Medicinal product

(Invented) name

REMERON

Active substance (s)

Mirtazapinas

Strength

15 mg

Pharmaceutical form

burnoje disperguojamos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N06AX11, Mirtazapine

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2026-01-09

Date of renewal

Documents

3114_3115_Remeron tab_PIL_2026-01-09.docx

3114_3115_Remeron tab_PZ_2026-01-09.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Mirtazapinas	15 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
119777	105883	1105883	lizdinė plokštelė	N30		Receptinis	LT/L/26/3114/001	Netiekiama	-	2026-02-23	No	-	-	Download
119778	105884	1105884	lizdinė plokštelė	N60		Receptinis	LT/L/26/3114/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2026-01-09	Registruotas